Advertisement
Review Article| Volume 42, ISSUE 2, P241-249, June 2021

Download started.

Ok

Clinical Relevance and Management of “Pre–Interstitial Lung Disease”

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribers receive full online access to your subscription and archive of back issues up to and including 2002.

      Content published before 2002 is available via pay-per-view purchase only.

      Subscribe:

      Subscribe to Clinics in Chest Medicine
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Rosas I.O.
        • Dellaripa P.F.
        • Lederer D.J.
        • et al.
        Interstitial lung disease: NHLBI workshop on the primary prevention of chronic lung diseases.
        Ann Am Thorac Soc. 2014; 11: S169-S177
        • Hatabu H.
        • Hunninghake G.M.
        • Richeldi L.
        • et al.
        Interstitial lung abnormalities detected incidentally on CT: a position paper from the Fleischner society.
        Lancet Respir Med. 2020; 8: 726-737
        • Raghu G.
        • Collard H.R.
        • Egan J.J.
        • et al.
        An official ATS/ERS/JRS/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management.
        Am J Respir Crit Care Med. 2011; 183: 788-824
        • Doyle T.J.
        • Hunninghake G.M.
        • Rosas I.O.
        Subclinical interstitial lung disease: why you should care.
        Am J Respir Crit Care Med. 2012; 185: 1147-1153
        • Mathai S.K.
        • Humphries S.
        • Kropski J.A.
        • et al.
        MUC5B variant is associated with visually and quantitatively detected preclinical pulmonary fibrosis.
        Thorax. 2019; 74: 1131-1139
        • Jin G.Y.
        • Lynch D.
        • Chawla A.
        • et al.
        Interstitial lung abnormalities in a CT lung cancer screening population: prevalence and progression rate.
        Radiology. 2013; 268: 563-571
        • Putman R.K.
        • Gudmundsson G.
        • Axelsson G.T.
        • et al.
        Imaging patterns are associated with interstitial lung abnormality progression and mortality.
        Am J Respir Crit Care Med. 2019; 200: 175-183
        • Hunninghake G.M.
        • Hatabu H.
        • Okajima Y.
        • et al.
        MUC5B promoter polymorphism and interstitial lung abnormalities.
        N Engl J Med. 2013; 368: 2192-2200
        • Putman R.K.
        • Hatabu H.
        • Araki T.
        • et al.
        Association between interstitial lung abnormalities and all-cause mortality.
        JAMA. 2016; 315: 672-681
        • Washko G.R.
        • Hunninghake G.M.
        • Fernandez I.E.
        • et al.
        Lung volumes and emphysema in smokers with interstitial lung abnormalities.
        N Engl J Med. 2011; 364: 897-906
        • Hoyer N.
        • Wille M.M.W.
        • Thomsen L.H.
        • et al.
        Interstitial lung abnormalities are associated with increased mortality in smokers.
        Respir Med. 2018; 136: 77-82
        • Podolanczuk A.J.
        • Oelsner E.C.
        • Barr R.G.
        • et al.
        High attenuation areas on chest computed tomography in community-dwelling adults: the MESA study.
        Eur Respir J. 2016; 48: 1442-1452
        • Doyle T.J.
        • Washko G.R.
        • Fernandez I.E.
        • et al.
        Interstitial lung abnormalities and reduced exercise capacity.
        Am J Respir Crit Care Med. 2012; 185: 756-762
        • Sverzellati N.
        • Guerci L.
        • Randi G.
        • et al.
        Interstitial lung diseases in a lung cancer screening trial.
        Eur Respir J. 2011; 38: 392-400
        • Tsushima K.
        • Sone S.
        • Yoshikawa S.
        • et al.
        The radiological patterns of interstitial change at an early phase: over a 4-year follow-up.
        Respir Med. 2010; 104: 1712-1721
        • Kropski J.A.
        • Pritchett J.M.
        • Zoz D.F.
        • et al.
        Extensive phenotyping of individuals at risk for familial interstitial pneumonia reveals clues to the pathogenesis of interstitial lung disease.
        Am J Respir Crit Care Med. 2015; 191: 417-426
        • Hunninghake G.M.
        • Quesada-Arias L.D.
        • Carmichael N.E.
        • et al.
        Interstitial lung disease in relatives of patients with pulmonary fibrosis.
        Am J Respir Crit Care Med. 2020; 201: 1240-1248
        • Doyle T.J.
        • Dellaripa P.F.
        • Batra K.
        • et al.
        Functional impact of a spectrum of interstitial lung abnormalities in rheumatoid arthritis.
        Chest. 2014; 146: 41-50
        • Gochuico B.R.
        • Avila N.A.
        • Chow C.K.
        • et al.
        Progressive preclinical interstitial lung disease in rheumatoid arthritis.
        Arch Intern Med. 2008; 168: 159-166
        • Kawano-Dourado L.
        • Doyle T.J.
        • Bonfiglioli K.
        • et al.
        Baseline characteristics and progression of a spectrum of interstitial lung abnormalities and disease in rheumatoid arthritis.
        Chest. 2020; 158: 1546-1554
        • Hoffmann-Vold A.M.
        • Fretheim H.
        • Halse A.K.
        • et al.
        Tracking impact of interstitial lung disease in systemic sclerosis in a complete nationwide cohort.
        Am J Respir Crit Care Med. 2019; 200: 1258-1266
        • Salisbury M.L.
        • Hewlett J.C.
        • Ding G.
        • et al.
        Development and progression of radiologic abnormalities in individuals at risk for familial interstitial lung disease.
        Am J Respir Crit Care Med. 2020; 201: 1230-1239
        • Lederer D.J.
        • Enright P.L.
        • Kawut S.M.
        • et al.
        Cigarette smoking is associated with subclinical parenchymal lung disease: the Multi-Ethnic Study of Atherosclerosis (MESA)-lung study.
        Am J Respir Crit Care Med. 2009; 180: 407-414
        • Rice M.B.
        • Li W.
        • Schwartz J.
        • et al.
        Ambient air pollution exposure and risk and progression of interstitial lung abnormalities: the Framingham Heart Study.
        Thorax. 2019; 74: 1063-1069
        • Sack C.
        • Vedal S.
        • Sheppard L.
        • et al.
        Air pollution and subclinical interstitial lung disease: the Multi-Ethnic Study of Atherosclerosis (MESA) air-lung study.
        Eur Respir J. 2017; 50: 1700559
        • Sack C.S.
        • Doney B.C.
        • Podolanczuk A.J.
        • et al.
        Occupational exposures and subclinical interstitial lung disease. The MESA (Multi-Ethnic study of atherosclerosis) air and lung studies.
        Am J Respir Crit Care Med. 2017; 196: 1031-1039
        • Rosas I.O.
        • Ren P.
        • Avila N.A.
        • et al.
        Early interstitial lung disease in familial pulmonary fibrosis.
        Am J Respir Crit Care Med. 2007; 176: 698-705
        • Seibold M.A.
        • Wise A.L.
        • Speer M.C.
        • et al.
        A common MUC5B promoter polymorphism and pulmonary fibrosis.
        N Engl J Med. 2011; 364: 1503-1512
        • Hobbs B.D.
        • Putman R.K.
        • Araki T.
        • et al.
        Overlap of genetic risk between interstitial lung abnormalities and idiopathic pulmonary fibrosis.
        Am J Respir Crit Care Med. 2019; 200: 1402-1413
        • Bernstein E.J.
        • Barr R.G.
        • Austin J.H.
        • et al.
        Rheumatoid arthritis-associated autoantibodies and subclinical interstitial lung disease: the Multi-Ethnic Study of Atherosclerosis.
        Thorax. 2016; 71: 1082-1090
        • Xu J.F.
        • Washko G.R.
        • Nakahira K.
        • et al.
        Statins and pulmonary fibrosis: the potential role of NLRP3 inflammasome activation.
        Am J Respir Crit Care Med. 2012; 185: 547-556
        • Gannon W.D.
        • Anderson M.R.
        • Podolanczuk A.J.
        • et al.
        Angiotensin receptor blockers and subclinical interstitial lung disease.
        MESA Study. 2019; 16: 1451-1453
        • Kim J.S.
        • Podolanczuk A.J.
        • Borker P.
        • et al.
        Obstructive sleep apnea and subclinical interstitial lung disease in the Multi-Ethnic Study of Atherosclerosis (MESA).
        Ann Am Thorac Soc. 2017; 14: 1786-1795
        • Miller E.R.
        • Putman R.K.
        • Vivero M.
        • et al.
        Histopathology of interstitial lung abnormalities in the context of lung nodule resections.
        Am J Respir Crit Care Med. 2018; 197: 955-958
        • Hung Y.P.
        • Hunninghake G.M.
        • Miller E.R.
        • et al.
        Incidental nonneoplastic parenchymal findings in patients undergoing lung resection for mass lesions.
        Hum Pathol. 2019; 86: 93-101
        • Axelsson G.T.
        • Putman R.K.
        • Araki T.
        • et al.
        Interstitial lung abnormalities and self-reported health and functional status.
        Thorax. 2018; 73: 884-886
        • Araki T.
        • Putman R.K.
        • Hatabu H.
        • et al.
        Development and progression of interstitial lung abnormalities in the Framingham Heart Study.
        Am J Respir Crit Care Med. 2016; 194: 1514-1522
        • Axelsson G.T.
        • Putman R.K.
        • Aspelund T.
        • et al.
        The associations of interstitial lung abnormalities with cancer diagnoses and mortality.
        Eur Respir J. 2020; 56: 1902154
        • Hoyer N.
        • Thomsen L.H.
        • Wille M.M.W.
        • et al.
        Increased respiratory morbidity in individuals with interstitial lung abnormalities.
        BMC Pulm Med. 2020; 20: 67
        • Raghu G.
        • Remy-Jardin M.
        • Myers J.L.
        • et al.
        Diagnosis of idiopathic pulmonary fibrosis. An official ATS/ERS/JRS/ALAT clinical practice guideline.
        Am J Respir Crit Care Med. 2018; 198: e44-e68
        • Suliman Y.A.
        • Dobrota R.
        • Huscher D.
        • et al.
        Brief report: pulmonary function tests: high rate of false-negative results in the early detection and screening of scleroderma-related interstitial lung disease.
        Arthritis Rheumatol. 2015; 67: 3256-3261
        • Showalter K.
        • Hoffmann A.
        • Rouleau G.
        • et al.
        Performance of forced vital capacity and lung diffusion cutpoints for associated radiographic interstitial lung disease in systemic sclerosis.
        J Rheumatol. 2018; 45: 1572-1576
        • Hoffmann-Vold A.-M.
        • Maher T.M.
        • Philpot E.E.
        • et al.
        The identification and management of interstitial lung disease in systemic sclerosis: evidence-based European consensus statements.
        Lancet Rheumatol. 2020; 2: e71-e83
        • Armstrong H.F.
        • Podolanczuk A.J.
        • Barr R.G.
        • et al.
        Serum matrix metalloproteinase-7, respiratory symptoms, and mortality in community-dwelling adults. MESA (Multi-Ethnic Study of Atherosclerosis).
        Am J Respir Crit Care Med. 2017; 196: 1311-1317
        • McGroder C.F.
        • Aaron C.P.
        • Bielinski S.J.
        • et al.
        Circulating adhesion molecules and subclinical interstitial lung disease: the Multi-Ethnic Study of Atherosclerosis.
        Eur Respir J. 2019; 54: 1900295
        • Sanders J.L.
        • Putman R.K.
        • Dupuis J.
        • et al.
        The association of aging biomarkers, interstitial lung abnormalities, and mortality.
        Am J Respir Crit Care Med. 2020; ([Epub ahead of print])